Sabatini, Silvia
Sabatini, Silvia
Istituto di Fisiologia Clinica - IFC
Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies
2024 Sabatini, S.; Nolan, J. J.; O(')Donoghue, G.; Kennedy, A.; Petrie, J.; Walker, M.; O(')Gorman, D. J.; Gastaldelli, A.
GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss
2024 Pepa, G. D.; Patricio, B. G.; Carli, F.; Sabatini, S.; Astiarraga, B.; Ferrannini, E.; Camastra, S.; Gastaldelli, A.
Hepatic glucose metabolism in the steatotic liver
2024 Scoditti, E.; Sabatini, S.; Carli, F.; Gastaldelli, A.
Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk
2023 Carli, Fabrizia; Sabatini, Silvia; Gaggini, Melania; Maria Sironi, Anna; Bedogni, Giorgio; Gastaldelli, Amalia
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals
2022 Saponaro, Chiara; Sabatini, Silvia; Gaggini, Melania; Carli, Fabrizia; Rosso, Chiara; Positano, Vincenzo; Armandi, Angelo; Caviglia, Gian Paolo; Faletti, Riccardo; Bugianesi, Elisabetta; Gastaldelli, Amalia
PPAR-?-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH
2021 Gastaldelli, A; Sabatini, S; Carli, F; Gaggini, M; Bril, F; Belfortdeaguiar, R; Positano, V; Barb, D; Kadiyala, S; Harrison, S; Cusi, K
What do central counterparty default funds really cover? A network-based stress test answer
2018 Poce, Giulia; Cimini, Giulio; Gabrielli, Andrea; Zaccaria, Andrea; Baldacci, Giuditta; Polito, Marco; Rizzo, Mariangela; Sabatini, Silvia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies | 1-gen-2024 | Sabatini, S.; Nolan, J. J.; O(')Donoghue, G.; Kennedy, A.; Petrie, J.; Walker, M.; O(')Gorman, D. J.; Gastaldelli, A. | |
| GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss | 1-gen-2024 | Pepa, G. D.; Patricio, B. G.; Carli, F.; Sabatini, S.; Astiarraga, B.; Ferrannini, E.; Camastra, S.; Gastaldelli, A. | |
| Hepatic glucose metabolism in the steatotic liver | 1-gen-2024 | Scoditti, E.; Sabatini, S.; Carli, F.; Gastaldelli, A. | |
| Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk | 1-gen-2023 | Carli, Fabrizia; Sabatini, Silvia; Gaggini, Melania; Maria Sironi, Anna; Bedogni, Giorgio; Gastaldelli, Amalia | |
| Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals | 1-gen-2022 | Saponaro, Chiara; Sabatini, Silvia; Gaggini, Melania; Carli, Fabrizia; Rosso, Chiara; Positano, Vincenzo; Armandi, Angelo; Caviglia, Gian Paolo; Faletti, Riccardo; Bugianesi, Elisabetta; Gastaldelli, Amalia | |
| PPAR-?-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH | 1-gen-2021 | Gastaldelli, A; Sabatini, S; Carli, F; Gaggini, M; Bril, F; Belfortdeaguiar, R; Positano, V; Barb, D; Kadiyala, S; Harrison, S; Cusi, K | |
| What do central counterparty default funds really cover? A network-based stress test answer | 1-gen-2018 | Poce, Giulia; Cimini, Giulio; Gabrielli, Andrea; Zaccaria, Andrea; Baldacci, Giuditta; Polito, Marco; Rizzo, Mariangela; Sabatini, Silvia |